{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:53:57Z","timestamp":1791996837451,"version":"4.4.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[1995,9,1]],"date-time":"1995-09-01T00:00:00Z","timestamp":809913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1995,9]]},"DOI":"10.1038\/nm0995-944","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T01:19:27Z","timestamp":1092878367000},"page":"944-949","source":"Crossref","is-referenced-by-count":502,"title":["Identification of endothelin\u20131 in the pathophysiology of metastatic adenocarcinoma of the prostate"],"prefix":"10.1038","volume":"1","author":[{"given":"Joel B.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Hedican","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H.","family":"Reddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Piantadosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario A.","family":"Eisenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnm0995944_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/canjclin.45.1.8","volume":"45","author":"PA Wingo","year":"1995","unstructured":"Wingo, P.A., Tong, T. & Bolden, S. Cancer statistics, 1995. CA Cancer J. Clin. 45, 8\u201330 (1995).","journal-title":"CA Cancer J. Clin."},{"key":"BFnm0995944_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/archsurg.1941.01210140043004","volume":"43","author":"C Huggins","year":"1941","unstructured":"Huggins, C., Stevens, R.E. & Hodges, C.V. Studies on prostate cancer. II. The effects of castration on advanced carcinoma of the prostate gland. Arch. Surg. 43, 209\u2013223 (1941).","journal-title":"Arch. Surg."},{"key":"BFnm0995944_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1200\/JCO.1993.11.4.607","volume":"11","author":"WK Kelly","year":"1993","unstructured":"Kelly, W.K. et al. Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer. J. clin. Oncol. 11, 607\u2013615 (1993).","journal-title":"J. clin. Oncol."},{"key":"BFnm0995944_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/332411a0","volume":"332","author":"M Yanagisawa","year":"1988","unstructured":"Yanagisawa, M. et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411\u2013415 (1988).","journal-title":"Nature"},{"key":"BFnm0995944_CR5","first-page":"223","volume":"74","author":"ML Casey","year":"1992","unstructured":"Casey, M.L., Byrd, W. & MacDonald, P.C. Massive amounts of immunoreactive endothelin in human seminal fluid. J. clin. Endoc. Metabol. 74, 223\u2013225 (1992).","journal-title":"J. clin. Endoc. Metabol."},{"key":"BFnm0995944_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0022-5347(17)35534-9","volume":"149","author":"P Langenstroer","year":"1993","unstructured":"Langenstroer, P. et al. Endothelin-1 in the human prostate: tissue levels, source of production and isometric tension studies. J. Urol. 149, 495\u2013499 (1993).","journal-title":"J. Urol."},{"key":"BFnm0995944_CR7","first-page":"306","volume":"45","author":"S Kobayashi","year":"1994","unstructured":"Kobayashi, S. et al. Binding and functional properties of endothelin receptor subtypes in the human prostate. Molec. Pharmacol. 45, 306\u2013311 (1994).","journal-title":"Molec. Pharmacol."},{"key":"BFnm0995944_CR8","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0022-5347(17)35083-8","volume":"151","author":"S Kobayashi","year":"1994","unstructured":"Kobayashi, S. et al. Localization of endothelin receptors in the human prostate. J. Urol. 151, 763\u2013766 (1994).","journal-title":"J. Urol."},{"key":"BFnm0995944_CR9","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1016\/S0021-9258(18)81823-3","volume":"264","author":"LL Muldoon","year":"1989","unstructured":"Muldoon, L.L., Rodland, K.D., Forsythe, M.L. & Magun, B.E. Stimulation of phosphatidylinositol hydrolysis, diacylglycerol release, and gene expression in response to endothelin, a potent new agonist for fibroblasts and smooth muscle cells. J. biol. Chem. 264, 8529\u20138536 (1989).","journal-title":"J. biol. Chem."},{"key":"BFnm0995944_CR10","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1042\/bj2630977","volume":"263","author":"KD Brown","year":"1989","unstructured":"Brown, K.D. & Littlewood, C.J. Endothelin stimulates DNA synthesis in Swiss 3T3 cells: Synergy with polypeptide growth factors. Biochem. J. 263, 977\u2013980 (1989).","journal-title":"Biochem. J."},{"key":"BFnm0995944_CR11","doi-asserted-by":"crossref","first-page":"20555","DOI":"10.1016\/S0021-9258(17)30538-0","volume":"265","author":"HE Shubeita","year":"1990","unstructured":"Shubeita, H.E. et al. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly and cardiac gene expression in ventricular myocytes. J. biol. Chem. 265, 20555\u201320562 (1990).","journal-title":"J. biol. Chem."},{"key":"BFnm0995944_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0196-9781(93)90057-N","volume":"14","author":"B Battistini","year":"1993","unstructured":"Battistini, B., Chailler, P., D'Orleans-Juste, P., Briere, N. & Sirois, P. Growth regulatory properties of endothelins. Peptides 14, 385\u2013399 (1993).","journal-title":"Peptides"},{"key":"BFnm0995944_CR13","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1172\/JCI115210","volume":"87","author":"M Schirchiri","year":"1991","unstructured":"Schirchiri, M. et al. Endothelin-1 is an autocrine\/paracrine growth factor for human cancer cell lines. J. clin. Invest. 87, 1867\u20131871 (1991).","journal-title":"J. clin. Invest."},{"key":"BFnm0995944_CR14","first-page":"E797","volume":"257","author":"Y Takuwa","year":"1989","unstructured":"Takuwa, Y., Ohue, Y., Takuwa, N. & Yamashita, K. Endothelin-1 activates phospholipase C and mobilizes Ca2+ from extra- and intracellular pools in osteoblastic cells. Am. J. Physiol. 257, E797\u2013803 (1989).","journal-title":"Am. J. Physiol."},{"key":"BFnm0995944_CR15","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/0006-291X(90)90491-5","volume":"170","author":"Y Takuwa","year":"1990","unstructured":"Takuwa, Y., Masaki, T. & Yamashita, K. The effects of the endothelin family peptides on cultured osteoblastic cells from rat calvariae. Biochem. biophys. Res. Commun. 170, 998\u20131005 (1990).","journal-title":"Biochem. biophys. Res. Commun."},{"key":"BFnm0995944_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0196-9781(92)90157-X","volume":"13","author":"I Schvartz","year":"1992","unstructured":"Schvartz, I., Ittoop, O., Davidai, G. & Hazum, E. Endothelin rapidly stimulates tyrosine phosphorylation in osteoblast-like cells. Peptides 13, 159\u2013163 (1992).","journal-title":"Peptides"},{"key":"BFnm0995944_CR17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/jcb.240530211","volume":"53","author":"M Shioide","year":"1993","unstructured":"Shioide, M. & Noda, M. Endothelin modulates osteopontin and osteocalcin messenger ribonucleic acid expression in rat osteoblastic osteosarcoma cells. J. cell. Biochem. 53, 176\u2013180 (1993).","journal-title":"J. cell. Biochem."},{"key":"BFnm0995944_CR18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/oxfordjournals.jbchem.a122925","volume":"106","author":"N Suzuki","year":"1989","unstructured":"Suzuki, N., Matsumoto, H., Kitada, C., Kimura, S. & Fujino, M. Production of endothelin-1 and big-endothelin-1 by tumour cells with epithelial-like morphology. J. Biochem. 106, 736\u2013741 (1989).","journal-title":"J. Biochem."},{"key":"BFnm0995944_CR19","first-page":"3257","volume":"50","author":"M Kusuhara","year":"1990","unstructured":"Kusuhara, M. et al. Production of endothelin in human cancer cell lines. Cancer Res. 50, 3257\u20133261 (1990).","journal-title":"Cancer Res."},{"key":"BFnm0995944_CR20","first-page":"1786","volume":"52","author":"MP Schrey","year":"1992","unstructured":"Schrey, M.P., Patel, K.V. & Tezapsidis, N. Bombesin and glucocorticoids stimulate human breast cancer cells to produce endothelin, a paracrine mitogen for breast stromal cells. Cancer Res. 52, 1786\u20131790 (1992).","journal-title":"Cancer Res."},{"key":"BFnm0995944_CR21","first-page":"554","volume":"52","author":"K Economos","year":"1992","unstructured":"Economos, K., MacDonald, P.C. & Casey, M.L. Endothelin-1 gene expression and biosynthesis in human endometrial HEC-1A cancer cells. Cancer Res. 52, 554\u2013557 (1992).","journal-title":"Cancer Res."},{"key":"BFnm0995944_CR22","first-page":"4046","volume":"52","author":"J Yamashita","year":"1992","unstructured":"Yamashita, J. et al. Abundant expression of immunoreactive endothelin-1 in mammary phyllodes tumour: Possible role of endothelin 1 in the growth of stromal cells in phyllodes tumour. Cancer Res. 52, 4046\u20134049 (1992).","journal-title":"Cancer Res."},{"key":"BFnm0995944_CR23","first-page":"464","volume":"53","author":"J Yamashita","year":"1993","unstructured":"Yamashita, J. et al. Interleukin 6 stimulates the production of immunoreactive endothelin 1 in human breast cancer cells. Cancer Res. 53, 464\u2013467 (1993).","journal-title":"Cancer Res."},{"key":"BFnm0995944_CR24","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1073\/pnas.86.8.2863","volume":"86","author":"A Inoue","year":"1989","unstructured":"Inoue, A. et al. The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. natn. Acad. Sci. U.S.A. 86, 2863\u20132867 (1989).","journal-title":"Proc. natn. Acad. Sci. U.S.A."},{"key":"BFnm0995944_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/335303b0","volume":"335","author":"C Takasaki","year":"1988","unstructured":"Takasaki, C., Yanagisawa, M., Kimura, S., Goto, K. & Masaki, T. Similarity of endothelin to snake venom toxin. Nature 335, 303 (1988).","journal-title":"Nature"},{"key":"BFnm0995944_CR26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/0041-0101(93)90111-U","volume":"31","author":"E Kochva","year":"1993","unstructured":"Kochva, E., Bdolah, A. & Wollberg, Z. Sarafotoxins and endothelins: Evolution, structure and function. Toxicon 31, 541\u2013568 (1993).","journal-title":"Toxicon"},{"key":"BFnm0995944_CR27","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/0041-0101(82)90052-6","volume":"20","author":"E Kochva","year":"1982","unstructured":"Kochva, E., Viljoen, C.C. & Botes, D.P. A new type of toxin in the venom of snakes of the genus Atractaspis (Atractaspidinae). Toxicon 20, 581\u2013592 (1982).","journal-title":"Toxicon"},{"key":"BFnm0995944_CR28","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/00004872-199009000-00004","volume":"8","author":"B Dahlof","year":"1990","unstructured":"Dahlof, B., Gustafsson, D., Hedner, T., Jern, S. & Hansson, L. Regional haemodynamic effects of endothelin-1 in rat and man: Unexpected adverse reactions. J. Hypertens. 8, 811\u2013817 (1990).","journal-title":"J. Hypertens."},{"key":"BFnm0995944_CR29","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/jnci\/85.8.611","volume":"85","author":"MA Eisenberger","year":"1993","unstructured":"Eisenberger, M.A. et al. Suramin, an active drug for prostate cancer: Interim observations in a phase I trial. J. natn. Cancer Inst. 85, 611\u2013621 (1993).","journal-title":"J. natn. Cancer Inst."},{"key":"BFnm0995944_CR30","first-page":"1566","volume":"19","author":"K Yamane","year":"1992","unstructured":"Yamane, K. et al. Significance of plasma endothelin-1 levels in patients with systemic sclerosis. J. Rheumatol. 19, 1566\u20131571 (1992).","journal-title":"J. Rheumatol."},{"key":"BFnm0995944_CR31","doi-asserted-by":"publisher","first-page":"S364","DOI":"10.1097\/00005344-199322008-00095","volume":"22","author":"S Ogawa","year":"1993","unstructured":"Ogawa, S., Zhang, J. & Yuge, K. Increased plasma endothelin-1 concentration in Kawasaki disease. J. Cardiovasc. Pharmacol. 22, S364\u2013366 (1993).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"BFnm0995944_CR32","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/0006-291X(89)92636-3","volume":"161","author":"P Cernacek","year":"1989","unstructured":"Cernacek, P. & Stewart, D.J. Immunoreactive endothelin in human plasma: Marked elevations in patients in cardiogenic shock. Biochem. biophys. Res. Commun. 161, 562\u2013567 (1989).","journal-title":"Biochem. biophys. Res. Commun."},{"key":"BFnm0995944_CR33","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0002-8703(05)80315-1","volume":"119","author":"M Yasuda","year":"1990","unstructured":"Yasuda, M. et al. Circulating immunoreactive endothelin in ischemic heart disease. Am. Heart J. 119, 801\u2013806 (1990).","journal-title":"Am. Heart J."},{"key":"BFnm0995944_CR34","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJM199110033251404","volume":"325","author":"A Lerman","year":"1991","unstructured":"Lerman, A. et al. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. New Engl. J. Med. 325, 997\u20131001 (1991).","journal-title":"New Engl. J. Med."},{"key":"BFnm0995944_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.7326\/0003-4819-114-3-213","volume":"114","author":"K Yokokawa","year":"1991","unstructured":"Yokokawa, K. et al. Hypertension associated with endothelin-secreting malignant hemangioendpthelioma. Ann. intern. Med. 114, 213\u2013215 (1991).","journal-title":"Ann. intern. Med."},{"key":"BFnm0995944_CR36","doi-asserted-by":"publisher","first-page":"S398","DOI":"10.1097\/00005344-199100177-00111","volume":"17","author":"K Yokokawa","year":"1991","unstructured":"Yokokawa, K. et al. Endothelin-secreting tumour. J. Cardiovasc. Pharmacol. 17, S398\u2013S401 (1991).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"BFnm0995944_CR37","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1056\/NEJM199312233292618","volume":"329","author":"P Cacoub","year":"1993","unstructured":"Cacoub, P., Dorent, R., Nataf, P. & Carayon, A. Endothelin-1 in pulmonary hypertension. New Engl. J. Med. 329, 1967\u20131968 (1993).","journal-title":"New Engl. J. Med."},{"key":"BFnm0995944_CR38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/00000658-199103000-00014","volume":"213","author":"JF Pittet","year":"1991","unstructured":"Pittet, J.F. et al. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann. Surg. 213, 261\u2013264 (1991).","journal-title":"Ann. Surg."},{"key":"BFnm0995944_CR39","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1161\/01.CIR.89.4.1580","volume":"89","author":"CM Wei","year":"1994","unstructured":"Wei, C.M. et al. Endothelin in human congestive heart failure. Circulation 89, 1580\u20131586 (1994).","journal-title":"Circulation"},{"key":"BFnm0995944_CR40","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1056\/NEJM199212173272502","volume":"327","author":"K Moore","year":"1992","unstructured":"Moore, K. et al. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. New Engl. J. Med. 327, 1774\u20131778 (1992).","journal-title":"New Engl. J. Med."},{"key":"BFnm0995944_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF02576362","volume":"194","author":"B Rolinski","year":"1994","unstructured":"Rolinski, B., Sadri, I., Bogner, J. & Goebel, F.D. Determination of endothelin-1 immunoreactivity in plasma, cerebrospinal fluid and urine. Res. exp. Med. 194, 9\u201324 (1994).","journal-title":"Res. exp. Med."},{"key":"BFnm0995944_CR42","first-page":"248","volume":"88","author":"M Nakamuta","year":"1993","unstructured":"Nakamuta, M. et al. High plasma concentrations of endothelin-like immunoreactivities in patients with hepatocellular carcinoma. Am. J. Gastroenterol. 88, 248\u2013252 (1993).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnm0995944_CR43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0168-8278(05)80584-7","volume":"19","author":"S Moller","year":"1993","unstructured":"Moller, S., Emmeluth, C. & Henriksen, J.H. Elevated circulating plasma endothelin-1 concentrations in cirrhosis. J. Hepatol. 19, 285\u2013290 (1993).","journal-title":"J. Hepatol."},{"key":"BFnm0995944_CR44","doi-asserted-by":"publisher","first-page":"7285","DOI":"10.1073\/pnas.86.18.7285","volume":"86","author":"MW MacCumber","year":"1989","unstructured":"MacCumber, M.W., Ross, C.A., Glaser, B.M. & Snyder, S.H. Endothelin: Visualization of mRNAs by in situ hybridization provides evidence for local action. Proc. natn. Acad. Sci. U.S.A. 86, 7285\u20137289 (1989).","journal-title":"Proc. natn. Acad. Sci. U.S.A."},{"key":"BFnm0995944_CR45","doi-asserted-by":"crossref","first-page":"16066","DOI":"10.1016\/S0021-9258(18)41966-7","volume":"267","author":"OF Wagner","year":"1992","unstructured":"Wagner, O.F. et al. Polar secretion of endothelin-1 by cultured endothelial cells. J. biol. Chem. 267, 16066\u201316088 (1992).","journal-title":"J. biol. Chem."},{"key":"BFnm0995944_CR46","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1096\/fasebj.5.12.1916094","volume":"5","author":"GM Rubanyi","year":"1991","unstructured":"Rubanyi, G.M. & Parker Botelho, L.H. Endothelins. FASEB J. 5, 2713\u20132720 (1991).","journal-title":"FASEB J."},{"key":"BFnm0995944_CR47","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/0006-2952(94)90038-8","volume":"48","author":"TD Warner","year":"1994","unstructured":"Warner, T.D., Battistini, B., Doherty, A.M. & Corder, R. Endothelin receptor antagonists: Actions and rationale for their development. Biochem. Pharmacol. 48, 625\u2013635 (1994).","journal-title":"Biochem. Pharmacol."},{"key":"BFnm0995944_CR48","first-page":"600","volume":"68","author":"B Battistini","year":"1993","unstructured":"Battistini, B., D'Orleans-Juste, P. & Sirois, P. Endothelins: Circulating plasma levels and presence in other biologic fluids. Lab. Invest. 68, 600\u2013628 (1993).","journal-title":"Lab. Invest."},{"key":"BFnm0995944_CR49","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1096\/fasebj.4.12.2168326","volume":"4","author":"MS Simonson","year":"1990","unstructured":"Simonson, M.S. & Dunn, M.J. Cellular signaling by peptides of the endothelin gene family. FASEB J. 4, 2989\u20133000 (1990).","journal-title":"FASEB J."},{"key":"BFnm0995944_CR50","first-page":"437","volume":"52","author":"EG Erdos","year":"1985","unstructured":"Erdos, E.G., Schulz, W.W., Gafford, J.T. & Defendini, R. Neutral metalloendopeptidase in human male genital tract: Comparison to angiotensin I-converting enzyme. Lab. Invest. 52, 437\u2013447 (1985).","journal-title":"Lab. Invest."},{"key":"BFnm0995944_CR51","first-page":"268","volume":"36","author":"C Papandreou","year":"1995","unstructured":"Papandreou, C. et al. Loss of neutral endopeptidase in androgen independent prostate cancers. Proc. Am. Assoc. Cancer Res. 36, 268 (1995).","journal-title":"Proc. Am. Assoc. Cancer Res."},{"key":"BFnm0995944_CR52","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1056\/NEJM198710083171501","volume":"317","author":"TA Stamey","year":"1987","unstructured":"Stamey, T.A. et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl. J. Med. 317, 909\u2013916 (1987).","journal-title":"New Engl. J. Med."},{"key":"BFnm0995944_CR53","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0022-5347(17)42630-9","volume":"139","author":"JE Oesterling","year":"1988","unstructured":"Oesterling, J.E. et al. Prostate-specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J. Urol. 139, 766\u2013779 (1988).","journal-title":"J. Urol."},{"key":"BFnm0995944_CR54","first-page":"6","volume":"78","author":"SA Rubin","year":"1994","unstructured":"Rubin, S.A. & Levin, E.R. The endocrinology of vasoactive peptides: Synthesis to function. J. clin. Endocr. Metabol. 78, 6\u201310 (1994).","journal-title":"J. clin. Endocr. Metabol."},{"key":"BFnm0995944_CR55","doi-asserted-by":"publisher","first-page":"429","DOI":"10.7326\/0003-4819-118-6-199303150-00006","volume":"118","author":"KH Polderman","year":"1993","unstructured":"Polderman, K.H. et al. Influence of sex hormones on plasma endothelin levels. Ann. intern. Med. 118, 429\u2013432 (1993).","journal-title":"Ann. intern. Med."},{"key":"BFnm0995944_CR56","first-page":"630","volume":"21","author":"HI Scher","year":"1994","unstructured":"Scher, H.I. & Chung, L.W.K. Bone metastases: Improving the therapeutic index. Semin. Oncol. 21, 630\u2013656 (1994).","journal-title":"Semin. Oncol."},{"key":"BFnm0995944_CR57","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1210\/endo.130.6.1597159","volume":"130","author":"ASMT Alam","year":"1992","unstructured":"Alam, A.S.M.T. et al. Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: Implications for the vascular control of bone resorption. Endocrinology 130, 3617\u20133624 (1992).","journal-title":"Endocrinology"},{"key":"BFnm0995944_CR58","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.7326\/0003-4819-67-6-1195","volume":"67","author":"S Charache","year":"1967","unstructured":"Charache, S. & Page, D.L. Infarction of bone marrow in the sickle cell disorders. Ann. intern. Med. 67, 1195\u20131200 (1967).","journal-title":"Ann. intern. Med."},{"key":"BFnm0995944_CR59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJM199107043250103","volume":"325","author":"OS Platt","year":"1991","unstructured":"Platt, O.S. et al. Pain in sickle cell disease: Rates and risk factors. New Engl. J. Med. 325, 11\u201316 (1991).","journal-title":"New Engl. J. Med."},{"key":"BFnm0995944_CR60","doi-asserted-by":"publisher","first-page":"S390","DOI":"10.1097\/00005344-199100177-00109","volume":"17","author":"HC Lam","year":"1991","unstructured":"Lam, H.C. et al. Immunoreactive endothelin in human plasma, urine, milk, and saliva. J. Cardiovasc. Pharmacol. 17, S390\u2013393 (1991).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"BFnm0995944_CR61","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1073\/pnas.69.6.1601","volume":"69","author":"AH Reddi","year":"1972","unstructured":"Reddi, A.H. & Huggins, C. Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proc. natn. Acad. Sci. U.S.A. 69, 1601\u20131605 (1972).","journal-title":"Proc. natn. Acad. Sci. U.S.A."},{"key":"BFnm0995944_CR62","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1210\/endo-107-5-1291","volume":"107","author":"AH Reddi","year":"1980","unstructured":"Reddi, A.H. & Sullivan, N.E. Matrix-induced endochondral bone differentiation influence of hypophysectomy, growth hormone, and thyroid-stimulating hormone. Endocrinology 107, 1291\u20131299 (1980).","journal-title":"Endocrinology"},{"key":"BFnm0995944_CR63","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry, O.H., Rosebrough, N.J., Farr, A.L. & Randall, R.J. Protein measurement with the Folin phenol reagent. J. biol. Chem. 193, 265 (1951).","journal-title":"J. biol. Chem."},{"key":"BFnm0995944_CR64","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2307\/3001469","volume":"12","author":"CY Kramer","year":"1956","unstructured":"Kramer, C.Y. Extension of multiple range tests to group means with unequal numbers of replications. Biometrics 12, 307\u2013310 (1956).","journal-title":"Biometrics"},{"key":"BFnm0995944_CR65","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/01621459.1952.10483441","volume":"47","author":"WH Kruskal","year":"1952","unstructured":"Kruskal, W.H. & Wallis, W.A. Use of ranks in one-criterion variance analysis. J. Am. Stat. Assoc. 47, 583\u2013621 (1952). Addendum, ibid. 48, 907\u2013911 (1953).","journal-title":"J. Am. Stat. Assoc."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0995-944","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0995-944.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0995-944.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:35:30Z","timestamp":1684452930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0995-944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,9]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1995,9]]}},"alternative-id":["BFnm0995944"],"URL":"https:\/\/doi.org\/10.1038\/nm0995-944","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,9]]}}}